A Phase IIa trial of TS-01 in patients suffering from acute ischemic stroke

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 06 Nov 2019

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs TS 01 (Primary)
Indications Stroke
Focus Adverse reactions; Proof of concept; Therapeutic Use

Most Recent Events

06 Nov 2019 Planned number of patients changed to 200.
30 Oct 2019 According to a Thrombolytic Science International media release, 10 patients has been enrolled in this study.
06 Sep 2018 According to a Thrombolytic Science media release, this study will be led by Prof. Diederik Dippel, MD, PhD, co-director of the Erasmus MC Stroke Center in Rotterdam, The Netherlands.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight